Dai 2011 Circ Res: Difference between revisions
No edit summary |
Bader Helga (talk | contribs) No edit summary Β |
||
(7 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
{{Publication | {{Publication | ||
|title=Dai DF, Johnson SC, Villarin JJ, Chin MT, Nieves-CintrΓ³n M, Chen T, Marcinek DJ, Dorn GW 2nd, Kang YJ, Prolla TA, Santana LF, Rabinovitch PS (2011) Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ | |title=Dai DF, Johnson SC, Villarin JJ, Chin MT, Nieves-CintrΓ³n M, Chen T, Marcinek DJ, Dorn GW 2nd, Kang YJ, Prolla TA, Santana LF, Rabinovitch PS (2011) Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ Res 108:837-46. | ||
|info=[http://www.ncbi.nlm.nih.gov/pubmed/21311045 PMID:21311045] | |info=[http://www.ncbi.nlm.nih.gov/pubmed/21311045 PMID: 21311045 Open Access] | ||
|authors=Dai DF, Johnson SC, Villarin JJ, Chin MT, Nieves-Cintron M, Chen T, Marcinek DJ, Dorn GW, Kang YJ, Prolla TA, Santana LF, Rabinovitch PS | |authors=Dai DF, Johnson SC, Villarin JJ, Chin MT, Nieves-Cintron M, Chen T, Marcinek DJ, Dorn GW, Kang YJ, Prolla TA, Santana LF, Rabinovitch PS | ||
|year=2011 | |year=2011 | ||
|journal=Circ | |journal=Circ Res | ||
|abstract=RATIONALE: Mitochondrial dysfunction has been implicated in several cardiovascular diseases; however, the roles of mitochondrial oxidative stress and DNA damage in hypertensive cardiomyopathy are not well understood. | |abstract=RATIONALE: Mitochondrial dysfunction has been implicated in several cardiovascular diseases; however, the roles of mitochondrial oxidative stress and DNA damage in hypertensive cardiomyopathy are not well understood. | ||
Line 12: | Line 12: | ||
CONCLUSIONS: These data indicate the critical role of mitochondrial ROS in cardiac hypertrophy and failure and support the potential use of mitochondrial-targeted antioxidants for prevention and treatment of hypertensive cardiomyopathy. | CONCLUSIONS: These data indicate the critical role of mitochondrial ROS in cardiac hypertrophy and failure and support the potential use of mitochondrial-targeted antioxidants for prevention and treatment of hypertensive cardiomyopathy. | ||
|keywords= | |keywords=Mitochondria, Reactive oxygen species, Angiotensin, Cardiomyopathy, Heart failure | ||
|mipnetlab= | |mipnetlab=US WA Seattle Marcinek DJ | ||
}} | }} | ||
{{Labeling | {{Labeling | ||
|organism=Mouse | |||
|tissues=Heart | |||
|preparations=Permeabilized tissue | |||
|injuries=Oxidative stress;RONS | |||
|instruments=Oxygraph-2k | |instruments=Oxygraph-2k | ||
}} | }} |
Latest revision as of 15:40, 19 March 2015
Dai DF, Johnson SC, Villarin JJ, Chin MT, Nieves-CintrΓ³n M, Chen T, Marcinek DJ, Dorn GW 2nd, Kang YJ, Prolla TA, Santana LF, Rabinovitch PS (2011) Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ Res 108:837-46. |
Dai DF, Johnson SC, Villarin JJ, Chin MT, Nieves-Cintron M, Chen T, Marcinek DJ, Dorn GW, Kang YJ, Prolla TA, Santana LF, Rabinovitch PS (2011) Circ Res
Abstract: RATIONALE: Mitochondrial dysfunction has been implicated in several cardiovascular diseases; however, the roles of mitochondrial oxidative stress and DNA damage in hypertensive cardiomyopathy are not well understood.
OBJECTIVE: We evaluated the contribution of mitochondrial reactive oxygen species (ROS) to cardiac hypertrophy and failure by using genetic mouse models overexpressing catalase targeted to mitochondria and to peroxisomes.
METHODS AND RESULTS: Angiotensin II increases mitochondrial ROS in cardiomyocytes, concomitant with increased mitochondrial protein carbonyls, mitochondrial DNA deletions, increased autophagy and signaling for mitochondrial biogenesis in hearts of angiotensin II-treated mice. The causal role of mitochondrial ROS in angiotensin II-induced cardiomyopathy is shown by the observation that mice that overexpress catalase targeted to mitochondria, but not mice that overexpress wild-type peroxisomal catalase, are resistant to cardiac hypertrophy, fibrosis and mitochondrial damage induced by angiotensin II, as well as heart failure induced by overexpression of GΞ±q. Furthermore, primary damage to mitochondrial DNA, induced by zidovudine administration or homozygous mutation of mitochondrial polymerase Ξ³, is also shown to contribute directly to the development of cardiac hypertrophy, fibrosis and failure.
CONCLUSIONS: These data indicate the critical role of mitochondrial ROS in cardiac hypertrophy and failure and support the potential use of mitochondrial-targeted antioxidants for prevention and treatment of hypertensive cardiomyopathy. β’ Keywords: Mitochondria, Reactive oxygen species, Angiotensin, Cardiomyopathy, Heart failure
β’ O2k-Network Lab: US WA Seattle Marcinek DJ
Labels:
Stress:Oxidative stress;RONS Organism: Mouse Tissue;cell: Heart Preparation: Permeabilized tissue
HRR: Oxygraph-2k